ExploreWatchlistsPricing
  1. JP-listed companies
  2. CanBas Co.,Ltd.
  3. Financials
  4. Return on equity (%)

CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on equity (%) (Million JPY)YoY (%)
Jun 30, 2025-43.8-22.61%
Jun 30, 2024-56.6-50.33%
Jun 30, 2023-114-54.13%
Jun 30, 2022-248.5+57.90%
Jun 30, 2021-157.4+22.70%
Jun 30, 2020-128.3+51.57%
Jun 30, 2019-84.6+7.28%
Jun 30, 2018-78.9+74.51%
Jun 30, 2017-45.2+3.15%
Jun 30, 2016-43.8+6.64%
Jun 30, 2015-41.1-47.06%
Jun 30, 2014-77.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat